Tristel plc (FRA:R1V)

Market Cap	227.52M
Revenue (ttm)	54.20M
Net Income (ttm)	7.75M
Shares Out	n/a
EPS (ttm)	0.16
PE Ratio	29.37
Forward PE	24.31
Dividend	0.16 (3.70%)
Ex-Dividend Date	Nov 27, 2025

Volume	953
Average Volume	99
Open	4.760
Previous Close	4.760
Day's Range	4.680 - 4.960
52-Week Range	3.040 - 5.100
Beta	n/a
RSI	71.38
Earnings Date	Nov 25, 2025

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 1993
• Employees: 267
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: R1V

Financial Performance

In 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.

Financial numbers in GBP